Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at different ways of giving radiotherapy for children and young people with medulloblastoma (HIT - SIOP PNET 4) (CNS 2003 05)

Overview

Cancer types:

Brain (and spinal cord) tumours, Children's cancers

Status:

Results

Phase:

Phase 3

Details

This trial compared standard radiotherapy with hyperfractionated radiotherapy (HFRT) for children and young people with medulloblastoma. This trial was supported by Cancer Research UK.

This trial was for children from 4 years old and young people up to and including the age of 21. We use the term 'you' in this summary, but of course if you are a parent, we are referring to your child.

Medulloblastoma is a type of brain tumour called a primitive neuroectodermal tumour (PNET). It grows in the hind brain (the cerebellum). It is the most common malignant brain tumour in children.

In some children, the medulloblastoma does not spread to the rest of the brain or spinal cord. Doctors call this ‘standard risk’. Treatment for standard risk medulloblastoma includes surgery to remove as much of the cancer as possible. But there may be cancer cells left behind. So children have radiotherapy and chemotherapy after surgery.

This trial tried to find the best way of giving radiotherapy to children with medulloblastoma. It compared the standard treatment of daily radiotherapy with hyperfractionated radiotherapy (HFRT). Children had HFRT twice a day instead of once. They had smaller doses, but the dose of radiotherapy overall was bigger. The researchers thought HFRT may kill more cancer cells than standard radiotherapy. The aim of the trial was to find out which method

  • Was better at stopping the cancer from coming back

  • Had the fewest side effects

Recruitment start: 1 December 2003

Recruitment end: 31 December 2006

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Barry Pizer

Supported by

Cancer Research UK

Cancer Research UK Children's Cancer Trials Team

University of Birmingham

National Institute for Health Research Cancer Research Network (NCRN)

Other information

This is Cancer Research UK trial number CRUK/03/012.

Last reviewed: 12 November 2012

CRUK internal database number: 358

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.